AVROBIO to Present at Three Upcoming Investor Conferences in March
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Stifel Starts Avrobio Inc. (AVRO) at Hold
March 1, 2021 4:09 PM ESTStifel analyst Dae Gon Ha initiates coverage on Avrobio Inc. (NASDAQ: AVRO) with a Hold rating and a price target of $14.00.
The analyst comments "We like the thesis of LV gene therapy and the potential to deliver durable therapeutic benefit from a... More
